This review summarizes existing animal models for studying antineoplastic therapy-induced cardiotoxicity and evaluates them based on macroscopic signs, echocardiography, and pathological morphology.
This review summarizes existing animal models for studying antineoplastic therapy-induced cardiotoxicity to guide future experimental and clinical research.
The continuous development of antineoplastic therapy has significantly reduced the mortality of patients with malignant tumors, but its induced cardiotoxicity has become the primary cause of long-term death in patients with malignant tumors. However, the pathogenesis of cardiotoxicity of antineoplastic therapy is currently unknown, and practical means of prevention and treatment are lacking in clinical practice. Therefore, how to effectively prevent and treat cardiotoxicity while treating tumors is a major challenge. Animal models are important tools for studying cardiotoxicity in antitumor therapy and are of great importance in elucidating pathophysiological mechanisms and developing and evaluating modality drugs. In this paper, we summarize the existing animal models in antitumor therapeutic cardiotoxicity studies and evaluate the models by observing the macroscopic signs, echocardiography, and pathological morphology of the animals, aiming to provide a reference for subsequent experimental development and clinical application.
Meng et al. (Sat,) conducted a review in Cardiotoxicity in antineoplastic therapy. Animal models of cardiotoxicity was evaluated. This review summarizes existing animal models for studying antineoplastic therapy-induced cardiotoxicity and evaluates them based on macroscopic signs, echocardiography, and pathological morphology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: